1. Home
  2. LEGN vs SOUN Comparison

LEGN vs SOUN Comparison

Compare LEGN & SOUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • SOUN
  • Stock Information
  • Founded
  • LEGN 2014
  • SOUN 2005
  • Country
  • LEGN United States
  • SOUN United States
  • Employees
  • LEGN N/A
  • SOUN N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • SOUN EDP Services
  • Sector
  • LEGN Health Care
  • SOUN Technology
  • Exchange
  • LEGN Nasdaq
  • SOUN Nasdaq
  • Market Cap
  • LEGN 5.4B
  • SOUN 4.6B
  • IPO Year
  • LEGN 2020
  • SOUN N/A
  • Fundamental
  • Price
  • LEGN $38.80
  • SOUN $10.11
  • Analyst Decision
  • LEGN Strong Buy
  • SOUN Buy
  • Analyst Count
  • LEGN 11
  • SOUN 7
  • Target Price
  • LEGN $74.60
  • SOUN $11.00
  • AVG Volume (30 Days)
  • LEGN 1.4M
  • SOUN 44.1M
  • Earning Date
  • LEGN 08-11-2025
  • SOUN 08-07-2025
  • Dividend Yield
  • LEGN N/A
  • SOUN N/A
  • EPS Growth
  • LEGN N/A
  • SOUN N/A
  • EPS
  • LEGN N/A
  • SOUN N/A
  • Revenue
  • LEGN $728,303,000.00
  • SOUN $102,228,000.00
  • Revenue This Year
  • LEGN $65.33
  • SOUN $92.14
  • Revenue Next Year
  • LEGN $54.68
  • SOUN $27.02
  • P/E Ratio
  • LEGN N/A
  • SOUN N/A
  • Revenue Growth
  • LEGN 112.46
  • SOUN 101.39
  • 52 Week Low
  • LEGN $27.34
  • SOUN $3.94
  • 52 Week High
  • LEGN $59.62
  • SOUN $24.98
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 47.38
  • SOUN 40.92
  • Support Level
  • LEGN $38.53
  • SOUN $10.25
  • Resistance Level
  • LEGN $45.30
  • SOUN $10.96
  • Average True Range (ATR)
  • LEGN 1.76
  • SOUN 0.80
  • MACD
  • LEGN -0.61
  • SOUN -0.28
  • Stochastic Oscillator
  • LEGN 9.73
  • SOUN 10.17

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About SOUN SoundHound AI Inc

SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.

Share on Social Networks: